Leading M&A Advisor to VMS CDMOs

Unrivalled sector experience.
International reach.
Proven execution.

Alantra is the leading M&A advisor to the vitamins, minerals and supplements (“VMS”) CDMO sector. Since 2020, we have completed 16 VMS CDMO transactions across 12 countries including seven in the last 18 months giving us an unmatched perspective on the companies, buyers and investors and individuals shaping the market.

The numbers speak for themselves:

16

VMS CDMO transactions
completed since 2020
7

Transactions completed
in the last 18 months
No. 1

M&A advisor to
European VMS CDMOs

Scroll down to see the latest transactions ↓

Deep expertise across the full VMS value chain

We advise founders, families, private equity investors and international corporate groups. Our track record spans the full breadth of VMS dosage formats, including capsules, tablets, powders, liquids, probiotics, softgels and gummies, as well as services such as R&D, category management and regulatory support. We are experienced across a wide range of end markets, from retail, pharmacy and drugstore to direct-to-consumer, subscription and omnichannel models.

Why clients choose Alantra

Buyer insight

Deep understanding of buyer priorities, market dynamics and value drivers to position every opportunity effectively.
Senior-led execution

Hands-on support throughout the transaction, combining strategic advice with disciplined execution.
Cross-border reach

A connected international platform combining local market knowledge with global execution capabilities.

Selected client feedback

Anders Björkell, Partner at CapMan

“The collaboration between your team, CapMan, and Pharmia’s management was excellent, and your strong sector expertise proved highly valuable. I am confident that Labomar is the ideal partner to support Pharmia’s continued growth.”
Alex Keibel, CEO & Founder of Aakamp

“Alantra were very knowledgeable of the VMS space in Europe and were able to run a tight process, supporting our team at a number of stages. A great result for us all, thank you!”
Jan Fletcher, (OBE) Chairman of Bee Health

“Their calm professionalism and in-depth knowledge of both our business and the sector in general, added significant value; importantly, they were also great to work with”
Martin Spengler, Managing Director at sanotact

“Alantra proved to be trusted and highly supportive partners from start to finish. They combined hands-on assistance in preparing key data and materials with clear, expert guidance through every stage of the transaction.”
Dr. Haymo Modelhart, FLOTTE

“With Alantra’s support, we are pleased to have secured a partnership with Avista and Damier that preserves the company’s values while supporting its next phase of growth.”
Roger Anné, Founder & Chairman of Aminolabs

“From day one, Alantra demonstrated a rare depth of knowledge of the nutrition manufacturing sector. Their guidance throughout the Zoka deal was very professional, responsive and always focused on the right outcome for all parties.

Selected VMS CDMO transactions

A track record built through repeated execution across the most active VMS markets.

Investment Banking